There was no question for Eilish that she wanted to use what happened to Aoife as a positive driving force for change, and so ...

Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spreadA collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously ...

Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting ...

Since February 2025, Elen Hughes has been treated with the drug capivasertib, the discovery of which was underpinned by research at The Institute of Cancer Research. She is now doing well and feels ...

PI3K inhibitors: decades of partnership between ICR researchers and industry leads to a new class of cancer drugs We share the story of a pioneering and collaborative research programme at the ICR, ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer.

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

Accelerating progress in drug development for the childhood brain cancer diffuse midline gliomaDiffuse midline gliomas (DMGs) are one of the most aggressive and hard-to-treat childhood cancers. These ...

Blood cancer is an umbrella term for cancers affecting the blood, bone marrow or lymphatic system.

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...